These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 31156651)

  • 1. Innate Immune Cells: A Potential and Promising Cell Population for Treating Osteosarcoma.
    Wang Z; Wang Z; Li B; Wang S; Chen T; Ye Z
    Front Immunol; 2019; 10():1114. PubMed ID: 31156651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of innate immune cells from human pluripotent stem cells.
    Bernareggi D; Pouyanfard S; Kaufman DS
    Exp Hematol; 2019 Mar; 71():13-23. PubMed ID: 30611869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate immune mediators in cancer: between defense and resistance.
    Berraondo P; Minute L; Ajona D; Corrales L; Melero I; Pio R
    Immunol Rev; 2016 Nov; 274(1):290-306. PubMed ID: 27782320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate immune recognition of cancer.
    Woo SR; Corrales L; Gajewski TF
    Annu Rev Immunol; 2015; 33():445-74. PubMed ID: 25622193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harnessing NK Cells for Cancer Treatment.
    Minetto P; Guolo F; Pesce S; Greppi M; Obino V; Ferretti E; Sivori S; Genova C; Lemoli RM; Marcenaro E
    Front Immunol; 2019; 10():2836. PubMed ID: 31867006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploiting dendritic cells and natural killer T cells in immunotherapy against malignancies.
    Fujii S
    Trends Immunol; 2008 May; 29(5):242-9. PubMed ID: 18372215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental evaluation of combined immunotherapy for tumors.
    Shubina IZh; Akhmatova NK; Donenko FV; Kiselevskii MV
    Bull Exp Biol Med; 2014 Sep; 157(5):620-2. PubMed ID: 25257426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells.
    Kim N; Kim HS
    Front Immunol; 2018; 9():2041. PubMed ID: 30250471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cell cross talk with innate and innate-like effector cells in antitumor immunity: implications for DC vaccination.
    van Beek JJ; Wimmers F; Hato SV; de Vries IJ; Sköld AE
    Crit Rev Immunol; 2014; 34(6):517-36. PubMed ID: 25597314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive networks and checkpoints controlling antitumor immunity and their blockade in the development of cancer immunotherapeutics and vaccines.
    Butt AQ; Mills KH
    Oncogene; 2014 Sep; 33(38):4623-31. PubMed ID: 24141774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of MicroRNAs in the development and function of innate immune cells.
    Kumar Kingsley SM; Vishnu Bhat B
    Int Rev Immunol; 2017 May; 36(3):154-175. PubMed ID: 28471289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are Conventional Type 1 Dendritic Cells Critical for Protective Antitumor Immunity and How?
    Cancel JC; Crozat K; Dalod M; Mattiuz R
    Front Immunol; 2019; 10():9. PubMed ID: 30809220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
    Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
    Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate immune cells for immunotherapy of autoimmune and cancer disorders.
    Schäfer C; Ascui G; Ribeiro CH; López M; Prados-Rosales R; González PA; Bueno SM; Riedel CA; Baena A; Kalergis AM; Carreño LJ
    Int Rev Immunol; 2017 Nov; 36(6):315-337. PubMed ID: 28933579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress and opportunities for immune therapeutics in osteosarcoma.
    Lettieri CK; Appel N; Labban N; Lussier DM; Blattman JN; Hingorani P
    Immunotherapy; 2016 Oct; 8(10):1233-44. PubMed ID: 27605071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Therapeutic Strategies for Solid Tumor Based on Body's Intrinsic Antitumor Immune System.
    Duan H
    Cell Physiol Biochem; 2018; 47(2):441-457. PubMed ID: 29794415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-cancer vaccine therapy for hematologic malignancies: An evolving era.
    Nahas MR; Rosenblatt J; Lazarus HM; Avigan D
    Blood Rev; 2018 Jul; 32(4):312-325. PubMed ID: 29475779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Killers at the crossroads: The use of innate immune cells in adoptive cellular therapy of cancer.
    Sabry M; Lowdell MW
    Stem Cells Transl Med; 2020 Sep; 9(9):974-984. PubMed ID: 32416056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sexual Dimorphism in Innate Immunity.
    Jaillon S; Berthenet K; Garlanda C
    Clin Rev Allergy Immunol; 2019 Jun; 56(3):308-321. PubMed ID: 28963611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systems approaches to unravel innate immune cell diversity, environmental plasticity and functional specialization.
    Soumelis V; Pattarini L; Michea P; Cappuccio A
    Curr Opin Immunol; 2015 Feb; 32():42-7. PubMed ID: 25588554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.